Circulating tumour cells in clinical practice: Methods of detection and possible characterization

被引:201
作者
Alunni-Fabbroni, Marianna [1 ]
Sandri, Maria Teresa [2 ]
机构
[1] Beckman Coulter Biomed GmbH, D-81377 Munich, Germany
[2] European Inst Oncol, Unit Lab Med, Milan, Italy
关键词
Circulating tumour cell; Enrichment method; Detection method; RT-PCR; Real time PCR; Immunomagnetic separation; Minimal residual disease; Cell characterization; RNA-POSITIVE CELLS; METASTATIC BREAST-CANCER; TIME RT-PCR; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD; BONE-MARROW; ADJUVANT CHEMOTHERAPY; MOLECULAR-DETECTION; SYSTEMIC THERAPY; EPITHELIAL-CELLS;
D O I
10.1016/j.ymeth.2010.01.027
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Circulating Tumour Cells (CTCs) can be released from the primary tumour into the bloodstream and may colonize distant organs giving rise to metastasis. The presence of CFCs in the blood has been documented more than a century ago, and in the meanwhile various methods have been described for their detection. Most of them require an initial enrichment step, since CFCs are a very rare event. The different technologies and also the differences among the screened populations make the clinical significance of CTCs detection difficult to interprete. Here we will review the different assays up to now available for CTC detection and analysis. Moreover, we will focus on the relevance of the clinical data, generated so far and based on the CFCs analysis. Since the vast majority of data have been produced in breast cancer patients, the review will focus especially on this malignancy. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 71 条
[1]   Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients [J].
Alix-Panabières, C ;
Brouillet, JP ;
Fabbro, M ;
Yssel, H ;
Rousset, T ;
Maudelonde, T ;
Choquet-Kastylevsky, G ;
Vendrell, JP .
JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 299 (1-2) :177-188
[2]   Detection and characterization of putative metastatic precursor cells in cancer patients [J].
Alix-Panabieres, Catherine ;
Vendrell, Jean-Pierre ;
Pelle, Olivier ;
Rebillard, Xavier ;
Riethdorf, Sabine ;
Mueller, Volkmar ;
Fabbro, Michel ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2007, 53 (03) :537-539
[3]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[4]   Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance [J].
Apostolaki, S. ;
Perraki, M. ;
Pallis, A. ;
Bozionelou, V. ;
Agelaki, S. ;
Kanellou, P. ;
Kotsakis, A. ;
Politaki, E. ;
Kalbakis, K. ;
Kalykaki, A. ;
Vamvakas, L. ;
Georgoulias, V. ;
Mavroudis, D. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :851-858
[5]  
Ashworth T.R., 1869, Australas Med J, V14, P146
[6]   Detection of circulating tumour cells in blood by quantitative real-time RT-PCR:: effect of pre-analytical time [J].
Benoy, Ina H. ;
Elst, Hilde ;
Van Dam, Peter ;
Scharpe, Simon ;
Van Marck, Eric ;
Vermeulen, Peter B. ;
Dirix, Luc Y. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (09) :1082-1087
[7]   Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene [J].
Bossolasco, P ;
Ricci, C ;
Farina, G ;
Soligo, D ;
Pedretti, D ;
Scanni, A ;
Deliliers, GL .
CANCER DETECTION AND PREVENTION, 2002, 26 (01) :60-63
[8]   Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. [J].
Braun, S ;
Pantel, K ;
Muller, P ;
Janni, W ;
Hepp, F ;
Kentenich, CRM ;
Gastroph, S ;
Wischnik, A ;
Dimpfl, T ;
Kindermann, G ;
Riethmuller, G ;
Schlimok, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :525-533
[9]   Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer [J].
Budd, G. Thomas ;
Cristofanilli, Massimo ;
Ellis, Mathew J. ;
Stopeck, Allison ;
Borden, Ernest ;
Miller, M. Craig ;
Matera, Jeri ;
Repollet, Madeline ;
Doyle, Gerald V. ;
Terstappen, Leon W. M. M. ;
Hayes, Daniel F. .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6403-6409
[10]   Prognostic significance of occult lymph node metastases in node-negative breast cancer [J].
Clare, SE ;
Sener, SF ;
Wilkens, W ;
Goldschmidt, R ;
Merkel, D ;
Winchester, DJ .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) :447-451